Swing and a miss! Hehehe
$Emergent BioSolutions(EBS.US$ Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.770) per share which missed the analyst consensus estimate of $(0.190) by 305.26 percent. The company reported quarterly sales of $276.600 million which missed the analyst consensus estimate of $293.533 million by 5.77 percent. This is a 16.36 percent decrease over sales of $330.700 million the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
